Who is sponsoring NCT03288116?

NCT03288116 is sponsored by Dar Al Shifa Hospital.

What drugs are being tested in NCT03288116?

Interventions in NCT03288116: Scheimplug imaging and contrast and sensitivity test.

What condition does NCT03288116 study?

NCT03288116 studies Keratoconus.

Is NCT03288116 still recruiting?

NCT03288116 is currently completed. Last updated 19 September 2017.

Last reviewed 2017-09-19 · How we verify

NCT03288116

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Objective and Subjective Diagnostic Parameters in the Fellow Eye of Unilateral Keratoconus

Completed Last updated 19 September 2017

What this trial tests

trial testing Scheimplug imaging and contrast and sensitivity test in Keratoconus in 48 participants. Completed in 5 February 2015.

Timeline

2 January 2014

Primary endpoint
5 February 2015

5 February 2015

Quick facts

Lead sponsor	Dar Al Shifa Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	48
Start date	2 January 2014
Primary completion	5 February 2015
Estimated completion	5 February 2015

Drugs / interventions tested

Scheimplug imaging and contrast and sensitivity test

Conditions studied

Keratoconus — all drugs for Keratoconus →

Sponsor

Dar Al Shifa Hospital

Who can join

Adults 14 to 44, any sex, with Keratoconus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

patients with keratoconus in one eye and forme fruste keratoconus in the fellow eye compared to normal subjects .the patients were examined by schemipflug imaging system (Pentacam)

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Keratoconus

Currently open trials in the same condition.

NCT07372911 — PRoTECT: Corneal Wavefront Guided PRK + Epi-off CXL vs. PTK+Epi-off CXL in Keratoconus · NA · recruiting
NCT07461129 — Electrophysiological Changes in Cases of Different Stages of Keratoconus · active not recruiting
NCT06601101 — Effects of Topical Insulin on Corneal Epithelium Healing After Corneal Crosslinking in Patients With Keratoconus · Phase 3 · recruiting
NCT05516004 — Safety and Effectiveness of the PXL-Platinum 330 System for Cornea Crosslinking in Eyes With Cornea Thinning · Phase 2 · recruiting
NCT06798779 — Predicting Manifest Astigmatism in Keratoconus Patients. · active not recruiting

Other Dar Al Shifa Hospital trials

Trials by the same sponsor.

NCT04904874 — Intense Pulsed Light Therapy in Meibomian Gland Dysfunction · NA · unknown
NCT04904887 — Clinical Outcomes With a New Monofocal IOL Enhanced for Intermediate Vision · NA · unknown
NCT04907955 — Visual Performance Following Implantation of Presbyopia Correcting IOLs · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03288116 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dar Al Shifa Hospital
Last refreshed: 19 September 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03288116.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing